Match each patient's clinical presentation of chronic cough with the most appropriate initial pharmacological intervention or management step.
- A 45-year-old man presents with an 8-week history of cough, predominantly at night, associated with frequent throat clearing and a sour taste in his mouth.Empirical trial of a proton pump inhibitor
- A 35-year-old woman presents with a 10-week history of dry cough, accompanied by a sensation of liquid dripping down the back of her throat and cobblestoning of the posterior pharynx.Empirical trial of an oral first-generation antihistamine-decongestant
- A 28-year-old man presents with a 3-month history of a nonproductive cough that worsens with exercise and cold air exposure; lung examination is unremarkable.Initiation of an inhaled corticosteroid
- A 62-year-old woman presents with a 6-month history of dry cough; her medical history is notable for hypertension treated with lisinopril and hydrochlorothiazide.Discontinuation of the angiotensin-converting enzyme inhibitor
Cevap
The correct matches pair GERD with a proton pump inhibitor, upper airway cough syndrome with a first-generation antihistamine-decongestant, cough-variant asthma with an inhaled corticosteroid, and ACE inhibitor-induced cough with medication discontinuation.
Chronic cough is defined as a cough lasting longer than 8 weeks. The most common causes are upper airway cough syndrome (UACS), asthma, gastroesophageal reflux disease (GERD), and medications (specifically ACE inhibitors). Patient 1 has typical GERD symptoms, making a proton pump inhibitor the best next step. Patient 2 describes UACS, which responds to a first-generation antihistamine-decongestant. Patient 3 has cough-variant asthma, appropriately managed with inhaled corticosteroids. Patient 4 is on an ACE inhibitor, which must be discontinued to determine if the cough resolves.
Adım Adım Çözüm
Anahtar Kavram
The evaluation and empirical management of chronic cough (lasting >8 weeks) in adults involves targeting the four most common etiologies: upper airway cough syndrome, asthma, gastroesophageal reflux disease, and ACE inhibitor use.